Join us in celebrating our autism patients all month long in honor of World Autism Month.

Stem cell therapy for cardiac valvular dysfunction

This patent application covers various mechanisms by which stem cell administration can inhibit the progression of valvular dysfunction, including mitral, aortic and semilunar valve regurgitation. The non-surgical regeneration of valve structures is highly desirable in patients that are not suitable to under highly invasive interventions due to age or other factors.